Hyperkalemia as a limiting factor of Neurohormonal Blockade/Modulation in everyday clinical practice
Aims Neurohormonal (NH) blockade/modulation is the core of Heart Failure with reduced Ejection Fraction (HFrEF) therapy. While improving long-term prognosis, it also induces hyperkalemia, which may increase mortality in the short-term. Thus, hyperkalemia frequently leads to withholding or reducing N...
Main Author: | |
---|---|
Format: | masterThesis |
Language: | eng |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10216/128673 |
Country: | Portugal |
Oai: | oai:repositorio-aberto.up.pt:10216/128673 |